Cell And Gene Therapies: Insights For Faster Batch Release

The rise of cell and gene therapies has transformed the life sciences landscape, introducing new complexities in development, manufacturing, and regulatory oversight. This era of innovation offers a unique opportunity for quality teams to move beyond compliance and become strategic partners in driving business success. By aligning quality initiatives with organizational goals, companies can navigate rapid change while maintaining patient safety and product integrity. Ed Taylor explores how quality can evolve from a reactive function to a proactive force that supports innovation, scalability, and long-term growth.

Discover why this shift matters and how it can position businesses for competitive advantage in a dynamic market.